Abstract
Background: Rattlesnake envenomation (RSE) causes edema, hemotoxicity and tissue necrosis. Necrosis may result in permanent disability.
Objective: To study patient-related factors associated with tissue necrosis after Crotalus envenomation.
Methods: Prospective cohort study of patients admitted to the Medical Toxicology service with diagnosis of RSE between April 2011 and November 2014. Inclusion criteria were age ≥18 years and upper extremity (UE) envenomation site. Primary outcome was tissue necrosis, including dermonecrosis, manifesting as bullae. Secondary outcome was amputation.
Results: 77 subjects, age 18 to 88 years, met inclusion criteria. Rattlesnake species was unknown in most cases. All received Fab antivenom. 62 (82%) had a digital envenomation. 31 (40.3%) had necrosis. Necrotic area ranged from 0.1 cm2 to 14 cm2. Procedural interventions, (superficial debridement, dermotomy, surgical exploration, and operative debridement of devitalized tissue) occurred in 25 (32.5%). Five (6.5%) underwent dermotomy and 6 (7.8%) operative debridement. No amputations were performed. Patients with cyanosis on presentation had increased risk of developing necrosis (11/12; RR 2.98 95% CI 1.99–4.46). Ecchymosis on presentation was also associated with increased risk of necrosis (24/32; RR 4.04 95% CI 2.08–7.86). Patients with social or regular ethanol use were more likely to develop necrosis than those without (28/53; RR 4.23 95% CI 1.42–12.6). Regular cocaine use was associated with increased risk of operative debridement (4/6; RR 9.13 95% CI 2.33–35.8). A nonsignificant risk of operative debridement occurred with tobacco use (RR 1.14 95%CI 0.99–1.31 p = 0.09). Time to antivenom did not correlate with risk of necrosis.
Conclusion: UE RSE patients who presented with cyanosis, ecchymosis or history of ethanol use were at increased risk of developing necrosis. Cocaine use was associated with increased risk of operative debridement.
Acknowledgements
The authors would like to thank the following medical toxicologists for their contribution to this study: Adam Bosak MD, Daniel Brooks MD, Steven Curry MD, Robert French MD, Kimberlie Graeme MD, Michael Levine MD, Rachel Levitan MD, Frank LoVecchio DO, Ayrn O’Connor MD, Aaron Skolnik MD, and An Tran DO.
Disclosure statement
The authors have no conflicts of interest nor financial disclosures.